Ling‐Ying Lu

436 total citations
31 papers, 311 citations indexed

About

Ling‐Ying Lu is a scholar working on Rheumatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Ling‐Ying Lu has authored 31 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 8 papers in Immunology and 6 papers in Immunology and Allergy. Recurrent topics in Ling‐Ying Lu's work include Systemic Lupus Erythematosus Research (8 papers), Allergic Rhinitis and Sensitization (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Ling‐Ying Lu is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Allergic Rhinitis and Sensitization (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Ling‐Ying Lu collaborates with scholars based in Taiwan, United States and Japan. Ling‐Ying Lu's co-authors include He‐Hsiung Cheng, Hui‐Wen Tseng, Yow‐Ling Shiue, Ping‐Hong Lai, H.‐C. Lam, Jingyuan Li, Patricia A. Fraser, Peter H. Schur, Wei‐Chun Huang and Angela Chen and has published in prestigious journals such as Neurology, International Journal of Molecular Sciences and Cytokine & Growth Factor Reviews.

In The Last Decade

Ling‐Ying Lu

28 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling‐Ying Lu Taiwan 10 158 122 49 37 35 31 311
Iván Posso‐Osorio Colombia 11 150 0.9× 112 0.9× 52 1.1× 38 1.0× 24 0.7× 55 326
Emma MacDermott Ireland 7 166 1.1× 164 1.3× 64 1.3× 36 1.0× 61 1.7× 18 334
Izumi Kurata Japan 10 107 0.7× 119 1.0× 41 0.8× 35 0.9× 23 0.7× 19 268
Evan S. Vista United States 11 201 1.3× 136 1.1× 24 0.5× 30 0.8× 34 1.0× 13 311
Ilfita Sahbudin United Kingdom 8 202 1.3× 76 0.6× 47 1.0× 52 1.4× 15 0.4× 20 345
S. John United Kingdom 8 118 0.7× 159 1.3× 49 1.0× 24 0.6× 50 1.4× 15 350
Ivana Nieto‐Aristizábal Colombia 9 188 1.2× 130 1.1× 28 0.6× 20 0.5× 23 0.7× 32 295
Seiji Segawa Japan 12 78 0.5× 179 1.5× 76 1.6× 30 0.8× 65 1.9× 17 320
Aarat Patel United States 8 158 1.0× 97 0.8× 32 0.7× 14 0.4× 19 0.5× 16 297
Juan Javier Lichauco Philippines 8 284 1.8× 171 1.4× 29 0.6× 17 0.5× 21 0.6× 12 397

Countries citing papers authored by Ling‐Ying Lu

Since Specialization
Citations

This map shows the geographic impact of Ling‐Ying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Ying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Ying Lu more than expected).

Fields of papers citing papers by Ling‐Ying Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Ying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Ying Lu. The network helps show where Ling‐Ying Lu may publish in the future.

Co-authorship network of co-authors of Ling‐Ying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Ying Lu. A scholar is included among the top collaborators of Ling‐Ying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Ying Lu. Ling‐Ying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chia‐Ling, et al.. (2025). House dust mite allergy exacerbates psoriasis by promoting hyperactivation of mast cells and Th17 cells. International Immunopharmacology. 164. 115336–115336.
2.
Tseng, Hui‐Wen & Ling‐Ying Lu. (2024). Short-term impact of exposure to ambient air volatile organic compounds on daily clinic visits for urticaria in Kaohsiung, Taiwan. Asian Pacific Journal of Allergy and Immunology. 43(3). 521–530. 1 indexed citations
3.
Hsieh, Tsu‐Yi, Ming‐Han Chen, Cheng‐Hsun Lu, et al.. (2023). Rituximab induction and reinduction in granulomatosis with polyangiitis and microscopic polyangiitis: A retrospective multicenter study in Taiwan. International Journal of Rheumatic Diseases. 26(12). 2441–2449.
4.
Lu, Ling‐Ying, et al.. (2022). Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review. Cytokine & Growth Factor Reviews. 63. 34–43. 15 indexed citations
5.
Li, Chia‐Ling, et al.. (2022). Forsythoside A Alleviates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Regulating Th17 Cells and IL-17A Expression. Journal of Personalized Medicine. 12(1). 62–62. 10 indexed citations
6.
Wang, Jyh‐Seng, et al.. (2019). Cerebellar PACNS in an Elderly Patient Present as a Tumor-Like Mass Lesion: A case Report.. PubMed. 28(2). 38–43. 1 indexed citations
7.
Tseng, Hui‐Wen, Ling‐Ying Lu, Hing‐Chung Lam, et al.. (2018). The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.. PubMed. 36(3). 471–478. 19 indexed citations
8.
Chen, Ji-Yih, et al.. (2018). Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese. Arthritis Research & Therapy. 20(1). 193–193. 31 indexed citations
9.
Liu, Po‐Yen, et al.. (2018). Nut sensitization profile in Southern Taiwan. Journal of Microbiology Immunology and Infection. 53(5). 791–796. 2 indexed citations
10.
Tsai, Chang‐Youh, et al.. (2011). Significant Decrease in Serum IL-6 and MMP-3 after Etanercept Treatment in Ankylosing Spondylitis Patients. 25. 11–19. 1 indexed citations
11.
Chen, Der-Yuan, Ning‐Sheng Lai, Ling‐Ying Lu, et al.. (2011). A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritis. Journal of the Chinese Medical Association. 74(12). 544–551. 3 indexed citations
12.
Lu, Ling‐Ying, et al.. (2008). Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.. PubMed. 41(2). 165–73. 6 indexed citations
13.
Lu, Ling‐Ying. (2007). Infections: Inseparable from Lupus?. 21(1). 1–3. 1 indexed citations
14.
15.
Lu, Ling‐Ying, et al.. (2007). TNF receptor I polymorphism is associated with persistent palindromic rheumatism. Scandinavian Journal of Rheumatology. 36(4). 278–284. 10 indexed citations
16.
Lu, Ling‐Ying, et al.. (2004). Primary Sjögren's syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement.. PubMed. 103(9). 707–10. 12 indexed citations
17.
Lu, Ling‐Ying, et al.. (2004). Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus.. PubMed. 37(3). 145–52. 27 indexed citations
18.
19.
Li, Jingyuan, et al.. (1999). Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjogren’s syndrome. Neurology. 52(2). 420–420. 50 indexed citations
20.
Lu, Ling‐Ying, et al.. (1997). Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis & Rheumatism. 40(6). 1138–1145. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iván Posso‐Osorio Breakdown of academic impact, for papers by Emma MacDermott Breakdown of academic impact, for papers by Izumi Kurata Breakdown of academic impact, for papers by Evan S. Vista Breakdown of academic impact, for papers by Ilfita Sahbudin Breakdown of academic impact, for papers by S. John Breakdown of academic impact, for papers by Ivana Nieto‐Aristizábal Breakdown of academic impact, for papers by Seiji Segawa Breakdown of academic impact, for papers by Aarat Patel Breakdown of academic impact, for papers by Juan Javier Lichauco
Rankless by CCL
2026